Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer
about
Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Tucatinib, Palbociclib and Let ...... nd HER2-positive Breast Cancer
@en
Tucatinib, Palbociclib and Let ...... nd HER2-positive Breast Cancer
@nl
type
label
Tucatinib, Palbociclib and Let ...... nd HER2-positive Breast Cancer
@en
Tucatinib, Palbociclib and Let ...... nd HER2-positive Breast Cancer
@nl
prefLabel
Tucatinib, Palbociclib and Let ...... nd HER2-positive Breast Cancer
@en
Tucatinib, Palbociclib and Let ...... nd HER2-positive Breast Cancer
@nl
P1476
Phase IB/II Open-label Single ...... itive Metastatic Breast Cancer
@en
P3098
NCT03054363
P580
2017-11-27T00:00:00Z
P582
2019-10-01T00:00:00Z